Vaccines - Premeditated genocide continues

[Guest guest]

Premeditated genocide continues Last week, Prof Francis Mmiro, the

lead investigator, said the baby [HIV] vaccine trial has been successful

so far, adding that he hoped the [HIV] vaccine will be added to the many

given to babies at birth and thereafter like polio, tetanus, hepatitis B

and measles. Preliminary results are expected by mid 2007 in the

two-and-and-half-year study. " - Esther Nakkazi, Nationmedia.com, The East

African

Barbara Loe Fisher Commentary:

 

There are different HIV (AIDS) vaccines in various stages of clinical

trials in the U.S. and other countries. In the past, evaluations of the

toxicity of experimental HIV (AIDS) vaccines were conducted in adults at

high risk for HIV infection, such as IV drug abusers and those with

multiple sexual partners. However, children have now become the

preferred testing ground for experimental HIV (AIDS) vaccines and will

be the eventual target for routine vaccination.

 

Newborn infants in Africa are now being enrolled in clinical trials. In

the U.S., future HIV vaccine trials will involve pre-adolescents and

babies.

 

A worldwide mass vaccination infrastructure is being created by

governments in partnership with multinational pharmaceutical companies,

the World Health Organization and private donors such as Bill Gates and

the Catholic Church. During the next decade, an international campaign

to vaccinate every man, woman and child with HIV (AIDS) vaccine will

begin and societal sanctions, including denial of an education and

health care, may well be levied against citizens in America and other

developed countries who refuse the HIV (AIDS) vaccine.

 

What many people do not realize is that the financing of world

vaccination campaigns are dependent upon forcing the citizens of wealthy

nations to purchase and use vaccines in order to finance the supply of

those same vaccines to underdeveloped countries at a reduced rate. For

example, hepatitis B disease is prevalent in Asia and Africa but has

never been in the U.S.; and HPV associated cervical cancer occurs at a

high rate in underdeveloped countries without routine pap smear

screening but cervical cancer is at an all time low in the U.S.. Still,

American children are forced to get hepatitis B vaccine or be denied an

education and the CDC has told told doctors that pre-adolescent American

girls must get HPV vaccine.

 

In 1996, HIV vaccine developer Stanley Plotkin, M.D., of Pasteur Merieux

Pharmaceuticals (who is a co-patent holder on rubella and rotavirus

vaccines) explained why mandatory vaccination in rich countries like the

U.S. help deliver vaccines to Third World markets:

 

" The keystone of the [global mass vaccination] system is that the

research costs [of drug companies] are recouped in North America and

Europe and the vaccines are sold in the developing world at much, much

lower margins...the relatively high rate of childhood vaccination seen

lately in most parts of the world is the result of that system, "

explained Plotkin.

 

One-size-fits-all forced vaccination policies target the genetically

vulnerable for injury and death and violate the human right to informed

consent to medical risk-taking. The casualties of mass vaccination

policies are never acknowledged or counted in the cost benefit analyses

drug companies and public health officials publish. This will be

especially true when the CDC announces every child in America must be

injected with just a little bit of the HIV (AIDS) virus.

 

No forced vaccination. Not in America.

 

 

Uganda launches HIV vaccine trials for babies

 

AllAfrica.com

The East African (Nairobi)

 

Click here for the URL:

<http://rs6.net/tn.jsp?t=qggys8bab.0.larzs8bab.oblmlwbab.3561 & ts=S0216 & p\

=http%3A%2F%2Fallafrica.com%2Fstories%2F200612270406.html>

http://tinyurl.com/yep7bq <http://tinyurl.com/yep7bq>

 

December 26, 2006

By ESTHER NAKKAZI

Special correspondent

 

Uganda has screened and vaccinated at least a quarter of the 50 babies

needed for vaccine trial focused on prevention of HIV transmission from

mother to child during breastfeeding.

 

The first baby in the vaccine trials was enrolled in October and by last

week 14 of them had received either the vaccine or placebo saline

solution (for control) while 16 have been screened to participate.

 

The study is in its phase I, randomised double blind - where the

researchers will not know which babies receive the vaccine or the

placebo solution, while 40 babies will randomly receive the vaccine and

10 the placebo.

 

In this first phase of the trial, the researchers are testing whether

the vaccine, formally known as Alvac-HIV, is safe for use in children,

following which they will study whether it can stop mother-to-child

transmission of the Aids-causing virus during breastfeeding.

 

Last week, Prof Francis Mmiro, the lead investigator, said the baby

vaccine trial has been successful so far, adding that he hoped the

vaccine will be added to the many given to babies at birth and

thereafter like polio, tetanus, hepatitis B and measles.

 

Preliminary results are expected by mid 2007 in the-two -and a half-year

study.

 

The Alvac-HIV vaccine is being given to children less than or equal to

three days of age, who weigh at least 2kg, have normal blood levels and

are born to HIV positive mothers.

 

The babies enrolled are also not participating in other trials, have not

received blood transfusions, do not have serious illnesses, and can be

monitored for 24 months. Their families should, therefore, be living

around Mulago referral hospital in Kampala.

 

The study primarily aims at evaluating the safety and immunogenicity of

the vaccine in infants born to HIV-infected women.

 

If successful, the vaccine could prevent at least 25,000 infections in

newborns in East Africa alone. The trial is being carried out by the

Uganda in collaboration with US Aids researchers.

 

Many children, especially in the developing world, are infected by their

HIV positive mothers who cannot afford to buy milk based formulas and

are forced to breastfeed them.

 

In Uganda, at least 8,000 babies were infected last year. At least

22,000 infections are registered in children each year.

 

So far, 535 women have been referred to Makerere University John Hopkins

Collaboration at Mulago Hospital.